Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

Horizon Technology Finance

National Science Foundation

Sahsen Ventures

Bioeconomy Capital

Soleus Capital

Janus Henderson Investors

Logos Capital

Marshall Wace

Saras Capital

Parse Biosciences

Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.

Qiagen

Mirxes is a biotechnology company that focuses on developing innovative solutions for single-cell analysis and sequencing.

Mirxes

GenScript is a biotechnology company that provides products and services for biological research, including single-cell sequencing technologies.

GenScript

RareCyte is a biotechnology company specializing in rare cell detection and analysis, including single-cell sequencing technologies.

RareCyte

JUMPCODE Genomics is a company that develops and provides advanced genomic analysis tools, including single-cell sequencing technologies.

JUMPCODE Genomics

Devyser is a biotechnology company that specializes in genetic testing solutions, including products for single-cell sequencing applications.

Devyser

ACD is a biotechnology company that develops and commercializes molecular and cellular analysis tools, including single-cell sequencing technologies.

Neogen Corporation is a company that provides products for food and animal safety, including genomic solutions that may include single-cell sequencing technologies.

Neogen

10x Genomics is a biotechnology company that develops and commercializes genomic analysis platforms, including single-cell sequencing technologies.

10x Genomics

Split Biosciences offers kits that enable researchers to perform single-cell sequencing, transforming the output into understandable results.

Split Biosciences

Parse Biosciences is a technology company that specializes in developing innovative solutions for single-cell sequencing. Their platforms aim to make single-cell analysis more accessible, scalable, and cost-effective, enabling researchers to unlock new insights into complex biological systems.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 12, 2024 6:43 PM	a69c0186
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	04c01538
crunchbase profile	general
li profile	general	May 12, 2024 6:43 PM	e7cb2b8b
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 12, 2024 6:43 PM	57e7459e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PARSEBIOSCIENCES

Parse Biosciences